Mylan

Mylan Launching Tecfidera Generic in US

Mylan announced the launch of a first generic version of Tecfidera, a treatment for relapsing forms of multiple sclerosis (MS). The generic, now approved by the U.S. Food and Drug Administration (FDA), is the first generic of any MS treatment available in an oral solid ā€”…

US Court Rules in Favor of Mylan, Generic Version of Tecfidera

Generic formulations of dimethyl fumarateĀ ā€” currently sold as Tecfidera by BiogenĀ ā€” were given a green light to enter the U.S. market, after a federal courtĀ invalidated a patent protecting Tecfidera from generic competition as aĀ multiple sclerosisĀ (MS) treatment.Ā  The ruling by the District Court for the…